ClinConnect ClinConnect Logo
Search / Trial NCT05275192

Utilization of a Videoscope in Periodontal Regeneration

Launched by UNIVERSITY OF ILLINOIS AT CHICAGO · Mar 1, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Periodontitis Minimally Invasive Surgery Videoscope Guided Tissue Regeneration Stage Iii, Grade B Periodontitis

ClinConnect Summary

This clinical trial is looking at how using a special camera called a videoscope during surgery can help improve the treatment of chronic periodontitis, a serious gum disease that can lead to tooth loss. The researchers want to see if the videoscope can help doctors see better during the procedure, which might lead to better healing of the gums and bones around the teeth. They will compare the outcomes of patients who receive the videoscope treatment to those who receive standard treatments over a period of 12 months.

To be eligible for the study, participants must be between 18 and 70 years old, in good health, and have at least one tooth with significant gum and bone damage. They should also be able to speak and understand English. If someone decides to participate, they will have a total of seven visits to the clinic over a year to monitor their progress, including taking images to assess healing. This study is being conducted at the Graduate Periodontics Clinic at the University of Illinois at Chicago College of Dentistry.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Individual must be between the age of 18 and 70 years of age
  • ASA I or II systemically healthy subjects
  • Individuals presenting with at least 1 single or multirooted tooth with residual, isolated, interproximal bony defect with probing depths (PD) ≥ 6 mm, clinical attachment loss (CAL) ≥ 6mm, bleeding upon probing (BOP), and ≥ 2mm width of attached gingiva (WAG)
  • Radiographic evidence of interproximal alveolar bone loss, on existing (\< 2 years old) dental radiographs of diagnostic quality taken at the COD
  • Vital tooth or previous root canal therapy with no signs/symptoms of pathology
  • Individuals with plaque scores ≤ 20%
  • English speaking subjects (Individual must be willing to follow all the study requirements and participate in the study procedures in its entirety and read, understand the informed consent form)
  • Exclusion Criteria:
  • Individuals not referred from the Predoctoral Periodontics Student Clinics
  • Uncontrolled systemic disorders such as hypertension, heart disease, bleeding disorders, metabolic bone diseases, autoimmune disorders, etc., that may influence cellular/healing status
  • Diabetics
  • Current smokers
  • Individual less than 18 years of age
  • Individuals with non-isolated, interproximal PD ≥ 4 mm extending to the facial/buccal and/or palatal/lingual tooth surfaces
  • Teeth with Grade 2 or 3 mobility
  • Teeth with metal restorations such as a porcelain fused to metal crown (due to scattering of radiographic images)
  • Intrabony defects on dental implants
  • Individual who take medications known to affect host immunity or periodontal tissues (ex. steroids, antibiotics, phenytoin, etc.) in the previous 6 months
  • Individuals on chronic anti-platelet/anti-coagulant therapy
  • Oral pathologies other than periodontal disease (ex. periapical lesions of non-periodontal origin)
  • Subjects who may be pregnant based on a positive pregnancy test
  • Non-English speaking individuals

About University Of Illinois At Chicago

The University of Illinois at Chicago (UIC) is a leading academic institution renowned for its commitment to advancing health sciences through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, UIC harnesses the expertise of its diverse faculty and state-of-the-art facilities to conduct cutting-edge clinical studies aimed at improving patient outcomes. The university's robust infrastructure for clinical research, combined with its dedication to ethical standards and regulatory compliance, positions UIC as a pivotal contributor to the development of new treatments and therapies in various medical fields. Through strategic partnerships and community engagement, UIC strives to translate research findings into real-world applications, enhancing the health and well-being of populations locally and globally.

Locations

Chicago, Illinois, United States

Patients applied

0 patients applied

Trial Officials

Salvador Nares, DDS, PhD

Principal Investigator

University of Illinois at Chicago

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials